The phrase "activate immune response" is correct and usable in written English.
It can be used in contexts related to biology, medicine, or immunology when discussing the triggering of the body's defense mechanisms against pathogens.
Example: "Vaccines work by introducing a harmless component of a virus to activate the immune response, preparing the body to fight off future infections."
Alternatives: "trigger immune response" or "stimulate immune response".
They are recognized as a source of cytokines such as IL-6 or receptor activator for nuclear factor-κ B ligand (RANKL), which activate immune response and osteoclastogenesis [ 2].
Immune rejection is primarily due to hyperacute rejection (HAR) where host antibodies target antigens on the surfaces of the transplanted cells (Krishnamurthy and Gimi, 2011), and sequentially activate immune response to eliminate those cells.
Both class I and II molecules are involved in displaying peptide antigen to host T lymphocytes in order to activate immune response [4].
The antibody contributes to activate immune response against tumor cells exploiting this mechanism of action.
They hypothesized that psychological intervention was associated with a shift from a constantly over activate immune response to a more, and better responding, adaptive immune status.
Cytokines are produced not only by immune cells but also by almost all cells and activate immune response during injury or infection.
The dynamic nature of NB-LRR localization to different subcellular compartments before and after activation suggests that NB-LRRs may activate immune responses in multiple parts of the cell.
Bacterial/viral CpG DNA and biological active synthetic oligodeoxynucleotides containing an unmethylated CpG motif (CpG ODN) activate immune responses in a toll-like receptor 9 (TLR9 -dependent manner.
Furthermore, alkylating agents have been shown to induce the secretion of ATP and HMGB1, both of which are danger signals that can activate immune responses against dying cells (Zong et al, 2004).
Furthermore, BAPCs were tested for in vivo delivery of a DNA vaccine previously designed to activate immune responses and capable of controlling tumors induced by type 16 human papilloma virus (HPV-16).
We propose that ER stress resulting from recognition of non-adapted viruses is utilized to discriminate "non-self" at the level of protein processing and to activate immune responses, with unintended consequences on pathogenesis.
